US Patent Issued to Elekta, The General Hospital on Nov. 25 for "Systems and methods to support personalization of cancer treatment for patients undergoing radiation therapy" (Dutch, American Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,801, issued on Nov. 25, was assigned to Elekta Inc. (Atlanta) and The General Hospital Corp. (Boston).

"Systems and methods to support personalization of cancer treatment for patients undergoing radiation therapy" was invented by Ali Ajdari (Boston), Thomas Reinhard Bortfeld (Cambridge, Mass.), Maria Luiza Bondar (Waalre, Netherlands) and Matthieu Frederic Bal (Geldrop, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "In providing radiation therapy (RT) support, a patient specific toxicity risk is estimated for a RT side effect using a Bayesian network that receives as inputs values of biomarkers of the patient. A patient-specific RT plan ...